Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $436

Author: Benzinga Newsdesk | April 19, 2024 07:05am
Baird analyst Mike Polark maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and lowers the price target from $440 to $436.

Posted In: ISRG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist